Kentaro Futatsugi

This inventor holds 31 USPTO granted patents and 14 published patent applications, plus 7 CIPO patents and 12 EPO patents, primarily in GLP-1 Receptor Agonists. Top assignee: Pfizer Corporation. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kentaro Futatsugi. Retrieved from https://idiyas.com/inventor/kentaro-futatsugi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 (Patent Applications = 14)

% Patents Active = 90.3

CIPO Patents = 7 (Patent Applications = 9)

EPO Patents = 12 (Patent Applications = 19)

Average Co-Inventor Count = 6.5

ph-index = 6

Forward Citations = 115(Granted Patents)

Location History:

Chita-gun, JP (2011)
Quincy, MA (US) (2016 - 2023)
Sharon, MA (US) (2020 - 2024)
Qunicy, MA (US) (2021 - 2024)

Company Filing History:

31 out of 4,488

Pfizer Corporation

patents

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

GLP-1 Receptor Agonists

Diacylglycerol Acyltransferase Inhibitors

Ketohexokinase Inhibitors

Benzodioxol

NASH

NAFLD

Prostaglandin EP3 Receptor

Bicyclocarboxyamide Compounds

Substituted 3-Azabicyclo

Combinations

Inhibitors

31 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12703696 - Diacylglycerol acyl transferase 2 inhibitors (2026-08-11),

2. 12611401 - Combinations comprising benzodioxol as GLP-1R agonists for use in the treatment of NASH/NAFLD and related diseases (2026-04-28),

3. 12378230 - GLP-1 receptor agonists and uses thereof (2025-08-05),

4. 12331041 - GLP-1 receptor agonists and uses thereof (2025-06-17),

5. 12319669 - GLP-1 receptor agonists and uses thereof (2025-06-03),

6. 11866425 - Diacylglycerol acyl transferase 2 inhibitors (2024-01-09),

7. 11858916 - GLP-1 receptor agonists and uses thereof (2024-01-02),

8. 11802121 - GLP-1 receptor agonists and uses thereof (2023-10-31),

9. 11634410 - Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors (2023-04-25),

10. 11512070 - GLP-1 receptor agonists and uses thereof (2022-11-29),

11. 11471458 - Diacylglycerol acyl transferase 2 inhibitor (2022-10-18),

12. 11065249 - Diacylglycerol acyl transferase 2 inhibitor (2021-07-20),

13. 11034678 - Diacylglycerol acyl transferase 2 inhibitors (2021-06-15),

14. 10988463 - Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors (2021-04-27),

15. 10934279 - GLP-1 receptor agonists and uses thereof (2021-03-02),

Title: Kentaro Futatsugi: Pioneering Inventor from Quincy

Introduction: Kentaro Futatsugi is a renowned inventor based in Quincy, Massachusetts, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Kentaro Futatsugi holds several patents in the areas of robotics, artificial intelligence, and sustainable energy solutions, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Kentaro Futatsugi has worked with leading tech companies to develop cutting-edge technologies that have revolutionized industries and improved the quality of life for many.

Collaborations: Throughout his career, Kentaro Futatsugi has collaborated with top researchers, engineers, and scientists from around the world, fostering a culture of innovation and excellence in all his projects.

Conclusion: Kentaro Futatsugi's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.